NCT07782541Completed
Presenting Patient-generated Data in axSpA Care
Evaluating and Co-designing a Secondary Care Clinical Dashboard for Presenting Patient-generated Health Data in Axial Spondyloarthritis (axSpA) Care.
Source: ClinicalTrials.gov · Last updated 24 Aug 2026
Brief summary (registry, in English)
Chronic health conditions are often managed in secondary care services that are facing long waiting lists, limited appointment times, and financial pressures. With the increasing availability of mobile devices including smartphones and wearables, patients can collect vast amounts of patient-generated health data (PGHD) outside of the clinic. This includes symptoms, biometrics and treatment adherence, providing clinicians with a more complete picture of patients' health. This data has the potential to support more insightful patient-clinician collaboration based on lived experiences; to enable remote clinical review; and ultimately, to improve the efficiency and quality of care. Clinicians and patients have expressed significant interest in using PGHD to manage their health, yet most attempts to review this data in clinic are unsuccessful. This project will investigate this problem with a case study in axial spondyloarthritis (axSpA) care. Firstly, a model will be created of how the axSpA care pathway works, including activities, data, and outcomes. Following this a newly implemented PGHD platform for axSpA care at the Royal United Hospitals (RUH) Bath will be evaluated. This evaluation will take place at the RUH, and will involve consultation observations and follow-up interviews with patients and clinicians. It will also involve a series of co-design workshops with patients and clinicians to explore their views on how the current platform may be optimised and improved, including their views on the potential value of predictive analytics. This research will provide insights how the platform is used during consultations, the barriers surrounding its uptake and impact across all parts of the axSpA model, and users' requirements for future versions.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 17 (actual)
- First submitted
- 18 Feb 2026
- Start date
- 10 Feb 2026
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Royal United Hospitals Bath NHS Foundation Trust
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT07782541
What you commit to
- Study type: Observational
- Participants enrolled: 17
- From 10 Feb 2026 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- The person believes that participation may cause them to feel distress, discomfort or embarrassment.
Who the study is looking for
- Adults over 18 with a diagnosis of axSpA
- Treated at the Royal National Hospital for Rheumatic Diseases, at the Royal United Hospitals Bath NHS Foundation Trust
- Due to have a planned consultation during the study period
- If participating in the interview via Teams, access to an electronic device (computer, laptop, tablet, or smartphone) and email address is required. If participating over the phone or via Teams, a quiet, private space is required to conduct the interview.
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal National Hospital for Rheumatic Diseases, at the Royal United Hospitals Bath NHS Foundation Trust Coordinator of this site? Confirm its status | Bath | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.